Death rates for the hydrocortisone group was not significantly lower than the placebo group; a total of 511 patients (27.9%) in the hydrocortisone group died compared to 526 (28.8%) in the placebo group (odds ratio, 0.85; 85% CI, 0.82 to 1.10; P=0.50).
The latest Vital Signs report from the Centers for Disease Control and Prevention (CDC) emphasizes the need for healthcare workers to use a combination of infection control recommendations to protect patients against antibiotic-resistant bacteria.
Injections received in the months prior to total knee or total hip replacement surgery may increase the risk for infection and related complications, according to 2 studies.
An abrupt decline in the number of reported tuberculosis (TB) cases among foreign-born persons in the United States began in 2007, according to research published online in PLOS ONE.
Allergan announced that the Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) to update the label for Dalvance (dalbavancin) for injection.
Despite recommendations for avoiding use of antibiotics for treatment of acute bronchitis because of lack of efficacy, many physicians continue to prescribe them.
For patients undergoing hepato-biliary-pancreatic surgery, having a lower blood glucose target is associated with reduced incidence of surgical site infection.
For patients with septic shock undergoing resuscitation, 28- and 90-day mortality is not significantly different with high- or low-target arterial pressure.